Concepedia

Publication | Open Access

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

DOIFull Paper Access

1.2K

Citations

23

References

2003

Year

David H. Miller, Omar Khan, William Sheremata, Lance D. Blumhardt, George P. Rice, Michele Libonati, A. Willmer–Hulme, Catherine M. Dalton, Katherine Miszkiel, Paul O’Connor
New England Journal of Medicine

Abstract

In a placebo-controlled trial, treatment with natalizumab led to fewer inflammatory brain lesions and fewer relapses over a six-month period in patients with relapsing multiple sclerosis.

References

YearCitations

Page 1